Cannabis Use Linked to Increased Diabetes Risk
A recent analysis involving over 4 million adults suggests a significant link between cannabis use and a nearly fourfold increase in diabetes risk. This finding is being shared at the Annual Meeting of the European Association for the Study of Diabetes, taking place in Vienna, Austria, from September 15 to 19.
Globally, cannabis use has been on the rise, with about 219 million users—roughly 4.3% of the adult population—reported in 2021. However, the long-term effects on metabolism remain somewhat unclear. While some research points to possible anti-inflammatory benefits or help with weight control, there are also concerns regarding glucose metabolism and insulin resistance. The exact extent of the diabetes risk associated with cannabis has not been fully established.
To delve deeper into this issue, Dr. Ibrahim Kamel and his team from Boston Medical Center analyzed electronic health records from a broad network of health care organizations. They identified 96,795 outpatients, aged 18 to 50 (with a female representation of 52.5%), who had various cannabis-related diagnoses from 2010 to 2018. These individuals were then matched with over 4 million healthy participants, ensuring similarities in age, sex, and health conditions at the beginning of the study, and were monitored for five years.
After accounting for factors like cholesterol levels, high blood pressure, cardiovascular diseases, and lifestyle habits, the researchers found that diabetes cases were significantly more prevalent among cannabis users—2.2% compared to 0.6% in the healthy group. This indicates that cannabis users have nearly quadruple the risk of developing diabetes compared to those who do not use cannabis.
While the study’s authors acknowledge the need for further investigation to clarify how exactly cannabis influences diabetes risk, they suggest that insulin resistance and poor dietary habits could be contributing factors. The findings are particularly relevant for healthcare practices and public health messages.
“As cannabis gains wider acceptance and legalization, understanding its health implications is crucial,” Dr. Kamel remarked. “This evidence emphasizes the importance of integrating awareness of diabetes risk into treatments for substance use disorders. Health professionals should routinely discuss cannabis use with patients to assess their overall risk for diabetes and the potential need for metabolic monitoring.”
It is vital to recognize, however, that this study is retrospective and does not prove a direct causal relationship between cannabis use and diabetes. Other unidentified factors might also play a role, even though steps were taken to minimize bias in the study’s methodology. Limitations arise from the lack of detailed information regarding cannabis consumption, as well as potential misclassification.
The authors further highlight challenges with real-world data, which can result from inconsistencies in how patients report their cannabis use in medical records. There’s also the risk of bias due to uncertain measures of cannabis exposure, especially among participants in areas where the substance remains illegal.
